ArticleFrontiers in immunology2025

Development and validation of a deep learning-based pathomics signature for prognosis and chemotherapy benefits in colorectal cancer: a retrospective multicenter cohort study.

Shenghan Lou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.